about
Carcinogen inducibility in vivo and down-regulation of DMBT1 during breast carcinogenesisGenome-wide association studies identify four ER negative-specific breast cancer risk lociGenome-wide association study identifies novel breast cancer susceptibility lociCommon breast cancer-predisposition alleles are associated with breast cancer risk in BRCA1 and BRCA2 mutation carriersGenome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer riskPrevalence of BRCA1 and BRCA2 mutations in Pakistani breast and ovarian cancer patientsLarge-scale genomic analyses link reproductive aging to hypothalamic signaling, breast cancer susceptibility and BRCA1-mediated DNA repairGenome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer TypesPALB2, CHEK2 and ATM rare variants and cancer risk: data from COGSLarge-scale genotyping identifies 41 new loci associated with breast cancer risk.Genome-wide association study identifies 25 known breast cancer susceptibility loci as risk factors for triple-negative breast cancer.Genetically Predicted Body Mass Index and Breast Cancer Risk: Mendelian Randomization Analyses of Data from 145,000 Women of European DescentIdentification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer.Male breast cancer in BRCA1 and BRCA2 mutation carriers: pathology data from the Consortium of Investigators of Modifiers of BRCA1/2.Comparison of 6q25 breast cancer hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC)ERCC2 genotypes and a corresponding haplotype are linked with breast cancer risk in a German population.Breast cancer: a candidate gene approach across the estrogen metabolic pathway.The CASP8 -652 6N del promoter polymorphism and breast cancer risk: a multicenter study.The CYP1B1_1358_GG genotype is associated with estrogen receptor-negative breast cancer.Ovarian cancer risk in Polish BRCA1 mutation carriers is not associated with the prohibitin 3' untranslated region polymorphism.Heterogeneity of breast cancer associations with five susceptibility loci by clinical and pathological characteristics.CYP2C19*17 is associated with decreased breast cancer risk.The influence of the Cyclin D1 870 G>A polymorphism as an endometrial cancer risk factor.Polymorphic loci of E2F2, CCND1 and CCND3 are associated with HER2 status of breast tumors.No evidence for glutathione S-transferases GSTA2, GSTM2, GSTO1, GSTO2, and GSTZ1 in breast cancer risk.TP53-based interaction analysis identifies cis-eQTL variants for TP53BP2, FBXO28, and FAM53A that associate with survival and treatment outcome in breast cancerGenes associated with histopathologic features of triple negative breast tumors predict molecular subtypes.CYP2D6 polymorphisms as predictors of outcome in breast cancer patients treated with tamoxifen: expanded polymorphism coverage improves risk stratification.Evaluation of Polygenic Risk Scores for Breast and Ovarian Cancer Risk Prediction in BRCA1 and BRCA2 Mutation CarriersPolymorphisms of the nuclear receptor pregnane X receptor and organic anion transporter polypeptides 1A2, 1B1, 1B3, and 2B1 are not associated with breast cancer risk.The frameshift polymorphism CYP3A43_74_delA is associated with poor differentiation of breast tumors.The CYP17A1 -34T > C polymorphism and breast cancer risk in BRCA1 and BRCA2 mutation carriers.German family study on hereditary breast-ovarian cancerLow frequency of BRCA1 germline mutations in 45 German breast/ovarian cancer familiesSystematic pathway enrichment analysis of a genome-wide association study on breast cancer survival reveals an influence of genes involved in cell adhesion and calcium signaling on the patients' clinical outcome.Common genetic variants and modification of penetrance of BRCA2-associated breast cancer2q36.3 is associated with prognosis for oestrogen receptor-negative breast cancer patients treated with chemotherapy.Exploring the link between MORF4L1 and risk of breast cancer.Identification of new genetic susceptibility loci for breast cancer through consideration of gene-environment interactions.
P50
Q24305437-E74F6AC4-5403-4481-AD81-DCFD7054E9CAQ24622610-EDC18E40-E320-4FA1-937D-EFBA45B24E22Q24645441-2D8D8AAF-FF14-4D68-AF19-680F55DB4BFCQ24655824-97337411-E000-4C30-874F-500FBCC32D99Q27008356-90F35204-AB5E-4B08-9586-860228BAB654Q28265357-2FC4E67A-31D2-43D6-AC1A-B03D604ED176Q28267893-FEF1955B-3BE1-423B-8F15-15D74AB15675Q28388497-56B1452E-B4A2-473E-BAB7-AD26F74C5816Q28584533-67157AA0-BF59-4625-AE85-9533C157D2A2Q29416989-BDE36DA5-03B5-4FD1-81C2-9B2BB56ACF0DQ29417100-915AC94F-17F8-4848-B60B-1C5B9C1A75B9Q30000080-3D478508-8749-4118-AB09-A469DCC132B6Q30252854-A24482D4-DEA7-4143-9850-498D71956AB2Q30374367-BEFAADFE-CA47-427A-9046-408D18AADF24Q31043651-66AF925D-A749-486F-9714-14F80B4DBE62Q31082788-30837CDC-DF31-4040-A035-238893410A78Q31136165-23A46243-0430-4D9B-933E-01CC83159A5CQ33288647-84A3844D-126E-480E-9047-4AF7B6D31E34Q33300099-7518BDF5-89A0-4622-B871-E4877188F115Q33301907-1D5674E1-EFA9-4304-820A-6B0B41FA0291Q33327308-E91CDD70-29A1-4D25-AD97-4B6BC2CE45CBQ33330850-C5B90286-4BC9-4740-86DD-5F08619B5FD5Q33339982-4FF52CE8-7DE5-4B08-8E6D-1701E23B9707Q33372463-B6C67DCC-3B63-4E75-9378-EEF80CCC4F08Q33399792-AD1E2D1A-FAC5-4128-9621-61083BAF0E46Q33512943-985E05AC-2821-4448-A8EA-4C114382C44BQ33566957-800BE194-DD9A-42EB-BE88-CB78863C5B5FQ33589487-3262D257-1B4A-4A32-A3FC-F81CD4203DE2Q33591915-7B6BA233-8EE4-49C1-9627-368CF676A550Q33614244-70875161-4837-4351-9A17-EC9344BE91BBQ33634168-8AFA43FF-506D-4EF6-8289-6B1023DB7FF2Q33660484-E1342CDC-9875-4171-86C6-07008E8F1C9CQ33675997-BACCF404-AF4D-4120-BC5F-6B4742138E32Q33677619-376BA753-FCCC-4940-8CBF-DB57ABD91B3AQ33679692-972958FB-1ADE-4432-92BF-B803DEE82A93Q33699957-004A6916-1C40-4E93-9EB3-8B3E17642051Q33742096-61939154-EF9F-4271-B09B-9C8CF1F34AE3Q33848895-CB719D20-D4BB-4D1D-9380-9BB4C10E5271Q33863235-C2BEDD0A-F386-4E43-BE4D-B9FDCDABE36BQ34038964-F7E405DA-8A16-469B-943A-11B105B8CDA9
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Ute Hamann
@ast
Ute Hamann
@en
Ute Hamann
@es
Ute Hamann
@nl
Ute Hamann
@sl
type
label
Ute Hamann
@ast
Ute Hamann
@en
Ute Hamann
@es
Ute Hamann
@nl
Ute Hamann
@sl
prefLabel
Ute Hamann
@ast
Ute Hamann
@en
Ute Hamann
@es
Ute Hamann
@nl
Ute Hamann
@sl